These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1096 related items for PubMed ID: 15773909

  • 1. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F.
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [Abstract] [Full Text] [Related]

  • 2. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MA, Ishrat T, Agrawal AK, Islam F.
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 4. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA, Peciña S, Schallert T, Stewart J.
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [Abstract] [Full Text] [Related]

  • 5. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    J Neurosci Methods; 2005 May 15; 144(1):35-45. PubMed ID: 15848237
    [Abstract] [Full Text] [Related]

  • 6. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.
    Zhongguo Zhong Yao Za Zhi; 2014 May 15; 39(9):1660-5. PubMed ID: 25095380
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K, Islam F.
    Brain Res; 2010 Apr 30; 1328():139-51. PubMed ID: 20167206
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease.
    Ahmad M, Yousuf S, Khan MB, Ahmad AS, Saleem S, Hoda MN, Islam F.
    Hum Exp Toxicol; 2006 Jul 30; 25(7):361-8. PubMed ID: 16898164
    [Abstract] [Full Text] [Related]

  • 9. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE, Cicchetti F, Hennen J, Isacson O.
    Exp Neurol; 2001 Dec 30; 172(2):363-76. PubMed ID: 11716560
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
    Delattre AM, Kiss A, Szawka RE, Anselmo-Franci JA, Bagatini PB, Xavier LL, Rigon P, Achaval M, Iagher F, de David C, Marroni NA, Ferraz AC.
    Neurosci Res; 2010 Mar 05; 66(3):256-64. PubMed ID: 19941911
    [Abstract] [Full Text] [Related]

  • 12. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H.
    Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471
    [Abstract] [Full Text] [Related]

  • 13. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Kondoh T, Bannai M, Nishino H, Torii K.
    Exp Neurol; 2005 Mar 28; 192(1):194-202. PubMed ID: 15698634
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar 28; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 15. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C, Nikkhah G, Cunningham MG, Björklund A.
    Exp Neurol; 1999 Sep 28; 159(1):177-90. PubMed ID: 10486186
    [Abstract] [Full Text] [Related]

  • 16. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N, Vidal L, Alvarez P, Blanco L, Torres A, Rodríguez A, Macías R.
    Rev Neurol; 1998 Jun 28; 26(154):915-8. PubMed ID: 9658459
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.
    van Oosten RV, Cools AR.
    Exp Neurol; 2002 Feb 28; 173(2):245-55. PubMed ID: 11822888
    [Abstract] [Full Text] [Related]

  • 18. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
    Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, Jenner P.
    Exp Neurol; 2008 Aug 28; 212(2):522-31. PubMed ID: 18571649
    [Abstract] [Full Text] [Related]

  • 19. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
    Friehs GM, Parker RG, He LS, Haines SJ, Turner DA, Ebner TJ.
    J Neural Transplant Plast; 1991 Aug 28; 2(2):141-56. PubMed ID: 1684115
    [Abstract] [Full Text] [Related]

  • 20. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
    Agrawal AK, Chaturvedi RK, Shukla S, Seth K, Chauhan S, Ahmad A, Seth PK.
    J Chem Neuroanat; 2004 Dec 28; 28(4):253-64. PubMed ID: 15531136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.